RL vs SPRO · P/E 24, rev $8.11B vs P/E 9.6, rev $48.0M
Ralph Lauren Corp Class A (RL) versus Spero Therapeutics Inc (SPRO) — a side-by-side from cached financials, not a winner call.
Ralph Lauren Corp Class A (RL) is a apparel manufacturing company listed on US.
Spero Therapeutics Inc (SPRO) is a biotechnology company listed on NASDAQ.
Latest reported RL revenue for 2026-03-28 was $8.11B. Net income was $941.1M. Revenue was up 14.6% from 2025-03-29 to 2026-03-28. RL currently screens at market cap $16.95B and trailing P/E 24.1.
Latest reported SPRO revenue for 2024-12-31 was $48.0M. Net income was -$68.6M. Revenue was down 53.8% from 2023-12-31 to 2024-12-31. SPRO currently screens at market cap $149.5M and trailing P/E 9.6.
RL currently screens at market cap $16.95B and trailing P/E 24.1. SPRO currently screens at market cap $149.5M and trailing P/E 9.6.
Not investment advice. Open the RL and SPRO stock pages for the full models.
Not investment advice.